• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

培养基成分对人源肝脏Hep G2细胞系药物代谢酶活性的影响。

The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived Hep G2 cell line.

作者信息

Doostdar H, Duthie S J, Burke M D, Melvin W T, Grant M H

机构信息

Department of Medicine & Therapeutics, University of Aberdeen, Scotland.

出版信息

FEBS Lett. 1988 Dec 5;241(1-2):15-8. doi: 10.1016/0014-5793(88)81021-4.

DOI:10.1016/0014-5793(88)81021-4
PMID:2848717
Abstract

When grown in the standard Dulbecco's medium the human liver derived Hep G2 hepatoma cell line shows only 10-20% of the cytochrome P-450-dependent mixed function oxidase (MFO) activity of freshly isolated human adult hepatocytes. However, the MFO activities and, to a lesser extent, the activities of UDP-glucuronyltransferase and glutathione-S-transferase can be increased by altering the composition of the growth medium. Modified Earle's medium was more effective in this respect than Williams' E medium and increased the O-dealkylations of ethoxyresorufin, benzyloxyresorufin and pentoxyresorufin 50-, 30- and 10-fold, respectively.

摘要

在标准的杜尔贝科培养基中培养时,源自人肝脏的Hep G2肝癌细胞系的细胞色素P - 450依赖性混合功能氧化酶(MFO)活性仅为新鲜分离的成人肝细胞的10% - 20%。然而,通过改变生长培养基的成分,可以提高MFO活性,在较小程度上也能提高尿苷二磷酸葡萄糖醛酸基转移酶和谷胱甘肽 - S - 转移酶的活性。在这方面,改良的厄尔培养基比威廉姆斯E培养基更有效,分别使乙氧试卤灵、苄氧试卤灵和戊氧试卤灵的O - 脱烷基化增加了50倍、30倍和10倍。

相似文献

1
The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived Hep G2 cell line.培养基成分对人源肝脏Hep G2细胞系药物代谢酶活性的影响。
FEBS Lett. 1988 Dec 5;241(1-2):15-8. doi: 10.1016/0014-5793(88)81021-4.
2
Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line.人肝癌Hep G2细胞系中的混合功能氧化酶和UDP-葡萄糖醛酸基转移酶活性
Biochem Pharmacol. 1988 Nov 1;37(21):4111-6. doi: 10.1016/0006-2952(88)90103-7.
3
The effects of dimethylsulphoxide and 5-aminolaevulinic acid on the activities of cytochrome P450-dependent mixed function oxidase and UDP-glucuronosyl transferase activities in human Hep G2 hepatoma cells.二甲基亚砜和5-氨基乙酰丙酸对人肝癌Hep G2细胞中细胞色素P450依赖的混合功能氧化酶及尿苷二磷酸葡萄糖醛酸基转移酶活性的影响
Biochem Pharmacol. 1991 Aug 22;42(6):1307-13. doi: 10.1016/0006-2952(91)90271-6.
4
The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HEPG2 hepatoma cells.
Biochem Pharmacol. 1993 Aug 17;46(4):629-35. doi: 10.1016/0006-2952(93)90548-b.
5
Variation in drug-metabolizing enzyme activities during the growth of human Hep G2 hepatoma cells.人肝癌Hep G2细胞生长过程中药物代谢酶活性的变化
Xenobiotica. 1990 Apr;20(4):435-41. doi: 10.3109/00498259009046859.
6
Human adult hepatocytes in primary monolayer culture. Maintenance of mixed function oxidase and conjugation pathways of drug metabolism.原代单层培养的成人肝细胞。药物代谢中混合功能氧化酶和结合途径的维持。
Biochem Pharmacol. 1987 Jul 15;36(14):2311-6. doi: 10.1016/0006-2952(87)90596-x.
7
Rat adult hepatocytes in primary pure and mixed monolayer culture. Comparison of the maintenance of mixed function oxidase and conjugation pathways of drug metabolism.原代纯培养和混合单层培养的大鼠成年肝细胞。药物代谢中混合功能氧化酶和结合途径维持情况的比较。
Biochem Pharmacol. 1991 Jul 5;42(2):373-9. doi: 10.1016/0006-2952(91)90725-k.
8
Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver.人类肝脏原发性和继发性肿瘤中的肝药物代谢酶。
Cancer Res. 1987 Jan 15;47(2):460-6.
9
Induction of cytochrome P450-dependent monooxygenase in serum-free cultured Hep G2 cells.
Biochem Pharmacol. 1995 Oct 26;50(9):1407-12. doi: 10.1016/0006-2952(95)02027-6.
10
Cytotoxicity of bile in human Hep G2 cells and in primary cultures of rat hepatocytes.胆汁对人肝癌细胞株Hep G2细胞和大鼠原代肝细胞培养物的细胞毒性。
Artif Organs. 1998 Oct;22(10):831-6. doi: 10.1046/j.1525-1594.1998.06088.x.

引用本文的文献

1
A Review on New Frontiers in Drug-Drug Interaction Predictions and Safety Evaluations with In Vitro Cellular Models.体外细胞模型在药物相互作用预测和安全性评估新前沿的综述
Pharmaceutics. 2025 Jun 6;17(6):747. doi: 10.3390/pharmaceutics17060747.
2
Microcystin-LR in Primary Liver Cancers: An Overview.微囊藻毒素-LR 在原发性肝癌中的研究进展。
Toxins (Basel). 2022 Oct 20;14(10):715. doi: 10.3390/toxins14100715.
3
Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.特异质性药物性肝损伤(iDILI)的临床前模型:迈向预测
Acta Pharm Sin B. 2021 Dec;11(12):3685-3726. doi: 10.1016/j.apsb.2021.11.013. Epub 2021 Nov 18.
4
Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes.人源肝细胞系与原代人肝细胞中药物代谢酶表达的相似性和差异。
Drug Metab Dispos. 2011 Mar;39(3):528-38. doi: 10.1124/dmd.110.035873. Epub 2010 Dec 13.
5
Modulation by extracellular matrices of monooxygenase and CYP1A1 induction in Hep G2 cells in serum-free culture.无血清培养中细胞外基质对 Hep G2 细胞单加氧酶和 CYP1A1 诱导的调节。
Cytotechnology. 1999 Sep;31(1-2):205-11. doi: 10.1023/A:1008036625328.
6
Characterization of the human hepatocellular carcinoma (hepg2) cell line as an in vitro model for cadmium toxicity studies.将人肝癌细胞系(HepG2)作为镉毒性研究的体外模型的特性研究。
In Vitro Cell Dev Biol Anim. 2004 May-Jun;40(5-6):172-82. doi: 10.1290/1543-706X(2004)40<172:COTHHC>2.0.CO;2.
7
Assay of free-radical toxicity and antioxidant effect on the Hep 3B cell line: a test survey using lindane.对Hep 3B细胞系的自由基毒性及抗氧化作用测定:使用林丹的试验性调查。
Cell Biol Toxicol. 1996 Feb;12(1):19-28. doi: 10.1007/BF00143391.
8
Co-variation of glutathione transferase expression and cytostatic drug resistance in HeLa cells: establishment of class Mu glutathione transferase M3-3 as the dominating isoenzyme.人宫颈癌HeLa细胞中谷胱甘肽转移酶表达与细胞毒性药物耐药性的共变关系:以μ类谷胱甘肽转移酶M3-3作为主要同工酶的确立
Biochem J. 1994 Jan 1;297 ( Pt 1)(Pt 1):59-67. doi: 10.1042/bj2970059.
9
Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.在生物人工肝中,原代肝细胞作为生物转化功能的来源比Hep G2细胞表现更优。
Ann Surg. 1994 Jul;220(1):59-67.
10
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model.在一种新型体内模型中对强效抗乙肝病毒药物(-)顺式-5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊烷-5-基]胞嘧啶的评估。
Antimicrob Agents Chemother. 1994 Mar;38(3):616-9. doi: 10.1128/AAC.38.3.616.